Abiopharma

Request for Trading Halt: Request for Trading Halt

The company’s liability position as of 30.6.26, by repayment dates

General Announcement: CLARIFICATION RELATING TO A MEDIA ARTICLE

Q2 / Semi-Annual Report for 2026

Nebius Group announces pricing of upsized private offering of $5.0 billion of convertible senior notes

Amylyx Pharmaceuticals Announces Pricing of an Upsized $500 Million Underwritten Public Offering of Common Stock

Aduro elige a Saipem para que le preste apoyo en ingeniería y aprovisionamiento para la primera instalación de HCT de este tipo en Chemelot

Aduro seleziona Saipem per il supporto alle attività di ingegneria e approvvigionamento per la sua prima struttura HCT nel suo genere (FOAK) a Chemelot

Aduro kiest Saipem voor engineering- en inkoopondersteuning voor de eerste-in-zijn-soort (‘FOAK’) HCT-faciliteit op Chemelot

Aduro beauftragt Saipem mit Ingenieurplanung und Beschaffung für erste HCT-Anlage ihrer Art („FOAK“) in Chemelot

Aduro choisit Saipem pour soutenir l’ingénierie et l’approvisionnement de son installation HCT pionnière à Chemelot

General Announcement: Portfolio Holdings

Litchfield Hills Research Reiterates Buy Rating and $66 Price Target; Faraday Future Global CEO YT Jia and the Founding Team Affirm Their Commitment to Long-Term Share Ownership

General Announcement: Portfolio Holdings

Sherritt Provides Update on Calling of Shareholder Meeting